Takeda Pharmaceutical Co Ltd (FRA:TKDA)
€ 12.7 -0.2 (-1.55%) Market Cap: 40.26 Bil Enterprise Value: 68.39 Bil PE Ratio: 45.03 PB Ratio: 0.85 GF Score: 75/100

Q2 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Oct 27, 2022 / 09:30AM GMT
Release Date Price: €12.7 (+1.60%)

Oct 27, 2022 / 09:30AM GMT
Presentation
Oct 27, 2022 / 09:30AM GMT

=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Director of IR
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Giles Platford
Takeda Pharmaceutical Company Limited - President of the Plasma-Derived Therapies Business Unit
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Masato Iwasaki
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division
* Teresa Bitetti
Takeda Pharmaceutical Company Limited - President of the Global Oncology Business Unit

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot